文献速递湿疹皮炎与荨麻疹

奥马珠单抗应答与慢性自发性荨麻疹中IFN-γ、IL-10及IL-31分泌细胞减少相关

Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticaria.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2020-05-22

该研究随访15例慢性自发性荨麻疹患者接受奥马珠单抗治疗5个月,评估临床症状、细胞结合IgE、嗜碱性粒细胞活化及T细胞亚群分泌细胞因子频率。7例完全应答、5例部分应答、3例无应答。UCT改善与IL-10、IL-31及IFN-γ分泌T细胞频率下降显著相关,提示奥马珠单抗除IgE依赖机制外还影响特定T细胞亚群。

要点

  • 奥马珠单抗治疗CSU可减少分泌IL-10、IL-31和IFN-γ的T细胞频率。
  • UCT改善与上述T细胞亚群频率下降显著相关。
  • FcεRI-bearing细胞上细胞结合IgE及FcεRI表达下降,但FcεRII表达细胞未变。

核心结论

  • 奥马珠单抗治疗CSU除作用于IgE依赖免疫机制外,还影响特定T细胞亚群,且与临床改善相关。

研究设计与样本

  • 前瞻性随访研究,纳入15例慢性自发性荨麻疹患者,起始奥马珠单抗治疗后随访5个月。

主要发现

  • 7例完全应答、5例部分应答、3例无应答。
  • FcεRI-bearing细胞上细胞结合IgE减少,FcεRII表达细胞上未减少,FcεRI表达下降。
  • FcεRI刺激后嗜碱性粒细胞活化增加,但敏感性未受影响;嗜碱性粒细胞和T细胞频率保持不变。
  • UCT改善与IL-10、IL-31及IFN-γ分泌T细胞频率下降显著相关。

临床怎么用

  • 奥马珠单抗治疗CSU的临床改善可能与T细胞亚群分泌谱变化相关,提示监测T细胞因子分泌或有助于理解应答机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The anti-IgE antibody omalizumab has been approved for the treatment of chronic spontaneous urticaria (CSU) in patients insufficiently responding to antihistamines. However, its mode of action in CSU is not clearly understood. OBJECTIVES: The aim of this study was to get a better insight in the immune mechanisms involved in clinical improvement of CSU patients treated with omalizumab. METHODS: Chronic spontaneous urticaria patients (n = 15) were followed for 5 months after initiation of omalizumab treatment. Clinical symptoms were assessed by UCT and CU-Q2 oL. Cell-bound IgE was quantified on both FcεRI- and FcεRII-expressing cell populations in peripheral blood. In addition, IgE and IgG as well as their receptors were measured on basophils, and basophil activation was assessed with different concentrations of anti-FcεRI and fMLP. Furthermore, the frequencies of different T-cell subsets secreting IL-5, IL-10, IL-31 or IFN-γ were analysed by ELISpot assay. RESULTS: Seven patients showed a full, five a partial and three no clinical response to omalizumab. Cell-bound IgE was reduced on FcεRI-bearing cells, but not on FcεRII-expressing cells. Likewise, the expression of FcεRI declined. Basophil activation increased upon FcεRI-stimulation while their sensitivity was not affected. Both basophil and T-cell frequencies remained unchanged. However, when comparing the individual response to omalizumab treatment with distinct T-cell subsets, a significant correlation was found between improved UCT and decreased frequencies of IL-10-, IL-31- and IFN-γ-secreting T cells. CONCLUSIONS: We here show that besides addressing IgE-dependent immune mechanisms, omalizumab treatment of CSU patients has effects on distinct T-cell subsets, which correlate with clinical improvement.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Rauber MM, Pickert J, Holiangu L, et al. Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2020. PMID: 31954076. doi:10.1111/jdv.16216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。